Plasma endocannabinoidome and fecal microbiota interplay in people with HIV and subclinical coronary artery disease: Results from the Canadian HIV and Aging Cohort Study.

Cardiovascular medicine Health sciences Immunology Medical specialty Medicine

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
16 Aug 2024
Historique:
received: 14 02 2024
revised: 07 05 2024
accepted: 02 07 2024
medline: 19 8 2024
pubmed: 19 8 2024
entrez: 19 8 2024
Statut: epublish

Résumé

Chronic HIV infection is associated with accelerated coronary artery disease (CAD) due to chronic inflammation. The expanded endocannabinoid system (eCBome) and gut microbiota modulate each other and are key regulators of cardiovascular functions and inflammation. We herein investigated the interplay between plasma eCBome mediators and gut microbiota in people with HIV (PWH) and/or subclinical CAD versus HIV-uninfected individuals. CAD was determined by coronary computed tomography (CT) angiography performed on all participants. Plasma eCBome mediator and fecal microbiota composition were assessed by tandem mass spectrometry and 16S rDNA sequencing, respectively. HIV infection was associated with perturbed plasma eCBome mediators characterized by an inverse relationship between anandamide and

Identifiants

pubmed: 39156649
doi: 10.1016/j.isci.2024.110456
pii: S2589-0042(24)01681-X
pmc: PMC11326910
doi:

Types de publication

Journal Article

Langues

eng

Pagination

110456

Informations de copyright

© 2024 The Author(s).

Déclaration de conflit d'intérêts

We have no competing interest to declare.

Auteurs

Ralph-Sydney Mboumba Bouassa (RS)

Department of Biological Sciences and CERMO-FC Research Centre, Université du Quebec à Montréal, Montreal, QC, Canada.
Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.

Giada Giorgini (G)

Research Center of the Institut Universitaire de Cardiologie et Pneumologie de Québec (CRIUCPQ), Université Laval.

Cristoforo Silvestri (C)

Research Center of the Institut Universitaire de Cardiologie et Pneumologie de Québec (CRIUCPQ), Université Laval.
Institut sur la Nutrition et les Aliments Fonctionnels (INAF) et Centre Nutrition, Santé et Société (NUTRISS), Université Laval, Québec City, QC, Canada.

Chanté Muller (C)

Research Center of the Institut Universitaire de Cardiologie et Pneumologie de Québec (CRIUCPQ), Université Laval.

Nayudu Nallabelli (N)

Research Center of the Institut Universitaire de Cardiologie et Pneumologie de Québec (CRIUCPQ), Université Laval.

Yulia Alexandrova (Y)

Department of Biological Sciences and CERMO-FC Research Centre, Université du Quebec à Montréal, Montreal, QC, Canada.

Madeleine Durand (M)

Centre de recherche du CHUM, Université de Montréal, Montreal, QC, Canada.

Cécile Tremblay (C)

Centre de recherche du CHUM, Université de Montréal, Montreal, QC, Canada.

Mohamed El-Far (M)

Centre de recherche du CHUM, Université de Montréal, Montreal, QC, Canada.

Carl Chartrand-Lefebvre (C)

Centre de recherche du CHUM, Université de Montréal, Montreal, QC, Canada.

Marc Messier-Peet (M)

Centre de recherche du CHUM, Université de Montréal, Montreal, QC, Canada.

Shari Margolese (S)

CIHR Canadian HIV Trials Network (CTN), Vancouver, BC, Canada.

Nicolas Flamand (N)

Research Center of the Institut Universitaire de Cardiologie et Pneumologie de Québec (CRIUCPQ), Université Laval.

Cecilia T Costiniuk (CT)

Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Division of Infectious Diseases/Chronic Viral Illness Service, McGill University Health Centre, Royal Victoria Hospital, Montreal, QC, Canada.

Vincenzo Di Marzo (V)

Research Center of the Institut Universitaire de Cardiologie et Pneumologie de Québec (CRIUCPQ), Université Laval.
Institut sur la Nutrition et les Aliments Fonctionnels (INAF) et Centre Nutrition, Santé et Société (NUTRISS), Université Laval, Québec City, QC, Canada.
Canada Excellence Research Chair on the Microbiome-Endocannabinoidome Axis in Metabolic Health, Université Laval.

Mohammad-Ali Jenabian (MA)

Department of Biological Sciences and CERMO-FC Research Centre, Université du Quebec à Montréal, Montreal, QC, Canada.

Classifications MeSH